Breaking
Friday, June 19, 2026

FDA News

🇺🇸 FDA Page 16

FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page

Track critical FDA approvals, regulatory updates, and policy shifts impacting drug development and market access in the US. Stay ahead of compliance.

Showing 181–192 of 391 articles

High impact AnalysisJun 2, 2026

FDA Misses Electric Shock Ban Deadline, Advocates Voice Concerns

FDA · 8 min

Dr. Sarah Mitchell
High impact NewsJun 2, 2026

FDA to Issue Guidance on Animal-Derived Thyroid Products by August 2026, Signaling Regulatory Shift

FDA · Graves' Disease · 8 min

Dr. Sarah Mitchell
High impact NewsJun 2, 2026

Global Regulatory Roundup: Key Updates for June 1, 2026

FDA · Dermatologicals · 7 min

Dr. Sarah Mitchell
High impact NewsJun 2, 2026

FDA Expert Panel to Review Peptide Access, Impacting Compounded Drug Market

FDA · 5 min

Dr. Sarah Mitchell
High impact NewsJun 2, 2026

Elite Pharma Files FDA ANDA for $26B Generic Blood Thinner, Targeting Key Anticoagulant Market

FDA · blood thinner · 6 min

Dr. Sarah Mitchell
High impact NewsJun 1, 2026

Medicus Pharma Ltd. to Present at Biotech Showcase 2026, Advancing SkinJect Program

FDA · 5 min

Dr. Sarah Mitchell
High impact NewsJun 1, 2026

Rigel Pharmaceuticals Licenses FDA-Approved Breast Cancer Drug VEPPANU

FDA · breast cancer · 7 min

Dr. Sarah Mitchell
High impact AnalysisJun 1, 2026

Merck's ADC Success: Insights from Global Trial Results

FDA · oncology · 8 min

Dr. Sarah Mitchell
High impact AnalysisJun 1, 2026

UCB's Bimzelx Triumphs Over AbbVie's Skyrizi in Psoriatic Arthritis

FDA · psoriatic arthritis · 7 min

Dr. Sarah Mitchell
High impact NewsJun 1, 2026

Accelerating Drug Development: FDA's AI Clinical Trials RFI Guide

FDA · 6 min

Dr. Sarah Mitchell
High impact AnalysisJun 1, 2026

Niowave's $75M Radiopharmaceutical Plant: Industry Implications

FDA · 8 min

Dr. Sarah Mitchell
High impact AnalysisJun 1, 2026

FDA Leadership Changes: Implications for the Pharmaceutical Industry

FDA · 5 min

Dr. Sarah Mitchell